Mangoceuticals, Inc. (MGRX)

Mangoceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	0.1	0.06	0.74	0.68
Cash & Short-Term Investments	0.1	0.06	0.74	0.68
Cash Growth	-79.39%	-92.06%	8.22%	-
Inventory	-	-	0.02	-
Other Current Assets	0.02	0.02	0.08	0.03
Total Current Assets	0.12	0.08	0.84	0.69
Net Property, Plant & Equipment	0.03	0.06	0.22	0.29
Other Intangible Assets	20.69	15.23	-	-
Other Long-Term Assets	-	-	-	0.19
Total Assets	20.84	15.37	1.05	1
Accounts Payable	0.77	0.84	0.14	0.03
Accrued Expenses	0.03	-	0.01	0
Short-Term Debt	0.6	0.15	-	0.17
Current Portion of Leases	0.03	0.06	0.06	0.06
Other Current Liabilities	0.17	0.37	-	-
Total Current Liabilities	1.6	1.43	0.21	0.26
Long-Term Leases	-	-	0.06	0.13
Total Long-Term Liabilities	-	-	0.06	0.13
Total Liabilities	1.6	1.43	0.28	0.39
Preferred Stock	0	0	-	-
Common Stock	0	0	0	0
Additional Paid-in Capital	50.89	34.76	12	2.63
Accumulated Other Comprehensive Income	-0	-0.01	-	-
Retained Earnings	-31.65	-20.81	-11.23	-2.02
Total Common Shareholders' Equity	19.24	13.95	0.77	0.61
Minority Interest	-0	-0	-	-
Shareholders' Equity	19.24	13.94	0.77	0.61
Total Liabilities & Equity	20.84	15.37	1.05	1
Total Debt	0.63	0.21	0.13	0.35
Net Cash (Debt)	-0.53	-0.16	0.61	0.33
Net Cash Growth	-	-	84.95%	-
Net Cash Per Share	-0.11	-0.08	0.57	0.46
Book Value	19.24	13.95	0.77	0.61
Book Value Per Share	4.01	7.05	0.72	0.85
Tangible Book Value	-1.45	-1.29	0.77	0.61
Tangible Book Value Per Share	-0.30	-0.65	0.72	0.85

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q